Travere Therapeutics, Inc. - COM (TVTX)

Historical Portfolio Holders from Q4 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
84.1 M
Holdings value Q1 2024
$648 M
Value change Q1 2024
+$15.6 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
164
Number of buys Q1 2024
91
Number of sells Q1 2024
-68
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
89422G107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 84.1 M $648 M +$15.6 M $7.71 165
2023 Q4 81.4 M $732 M -$10.2 M $8.99 163
2023 Q3 81.4 M $727 M -$62.5 M $8.94 168
2023 Q2 82.6 M $1.27 B -$87.6 M $15.36 164
2023 Q1 84.1 M $1.89 B +$265 M $22.49 172
2022 Q4 72.7 M $1.53 B +$30.9 M $21.03 151
2022 Q3 64.8 M $1.6 B -$1.53 M $24.64 159
2022 Q2 68.9 M $1.67 B +$17.1 M $24.23 162
2022 Q1 67.7 M $1.74 B +$101 M $25.77 164
2021 Q4 60.6 M $1.88 B +$62.2 M $31.04 164
2021 Q3 60.8 M $1.47 B +$7.96 M $24.25 145
2021 Q2 60.5 M $883 M -$73.5 M $14.59 130
2021 Q1 62.6 M $1.56 B +$255 M $24.97 148
2020 Q4 52.2 M $1.42 B +$1.41 B $27.26 135